Dissenting Statement of Commissioner Rohit Chopra In the Matter of AbbVie Inc. and Allergan plc

Tags:

• Health Care
• Prescription Drugs
• Manufacturing
• Pharmaceuticals
• Competition
• Merger
• Horizontal
• Bureau of Competition